title: Positron emission tomography-computed tomography imaging for malignancies in women.
abstract: The role of Positron Emission Tomography/Computed Tomography (PET/CT) in the evaluation of various gynecologic malignancies in light of current available data is presented and illustrated with imaging examples, pearls, and common pitfalls. 18F-fluorodeoxyglucose PET/CT is being increasingly used in management of gynecologic malignancy and has useful applications in cervical, ovarian, and endometrial carcinoma. Sensitivity and specificity are superior compared with conventional imaging. However, there are limitations of which the reporting physician should be aware. This article introduces the available evidence and discusses the role of PET/CT in various gynecologic malignancies and highlights imaging pearls and potential pitfalls.
authors.affiliation: Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1473, Houston, TX 77030, USA. Electronic address: chitra.viswanathan@mdanderson.org.
authors.forename: Chitra
authors.initials: C
authors.lastname: Viswanathan
authors.forename: Priya R
authors.initials: PR
authors.lastname: Bhosale
authors.forename: Shetal N
authors.initials: SN
authors.lastname: Shah
authors.forename: Raghunandan
authors.initials: R
authors.lastname: Vikram
mesh_terms: D003937:Diagnosis, Differential; D005260:Female; D019788:Fluorodeoxyglucose F18; D005833:Genital Neoplasms, Female / Q000000981:diagnostic imaging*; D006801:Humans; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: Cervical cancer; Endometrial cancer; Gynecologic malignancy; PET/CT; Pitfalls